Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 13Gastrointestinal 10Gynecologic 9Genitourinary 9Breast 7Head & Neck 5CNS 4Sarcoma 3Other hematologic neoplasm 3Myeloid 3Endocrine 3NET 2Tumor-Agnostic 1Other neoplasm 1Lymphoid 1Dermatologic 1

Conditions

Precancerous Conditions 10Neoplasms 3Keratosis, Actinic 3Skin Diseases 2Preleukemia 2Obesity-Related Malignant Neoplasm 2Neoplasms by Histologic Type 2Myelodysplastic Syndromes 2Leukemia, Myeloid, Acute 2Leukemia, Biphenotypic, Acute 2Leukemia 2Immunoproliferative Disorders 2Immune System Diseases 2Hematologic Diseases 2Endometrial Neoplasms 2Bone Marrow Diseases 2Venentoclax 1Uterine Prolapse 1Uterine Cervical Neoplasms 1Syndrome 1Stomach Neoplasms 1Rectal Malignant Neoplasms 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Pathologic Processes 1Pancreatic Neoplasms 1Ovarian Neoplasms 1Neoplasms by Site 1Multiple Myeloma 1Metrorrhagia 1Menstruation Disturbances 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Neoplasms by Site × Other neoplasm × 90 days × Clear all
NCT07216443 2026-04-15

Trial of Orca-T Following Reduced Intensity or Nonmyeloablative Conditioning in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome

Orca Biosystems, Inc.

Phase 2 Recruiting
80 enrolled
MyeloidOther hematologic neoplasmOther neoplasm

Acute Disease, Bone Marrow Diseases, Disease, Graft vs Host Disease, Hematologic Diseases, Immune System Diseases, Immunoproliferative Disorders, Leukemia, Myelodysplastic Syndromes, Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Pathologic Processes, Precancerous Conditions, Preleukemia, Syndrome, Leukemia, Biphenotypic, Acute, Leukemia, Myeloid, Acute, Hematologic Neoplasms, Disease Attributes

Data powered by HemOnc (CC BY 4.0) Colophon âš¡